explain glp-1 and Anesthesia: Considerations and Cautions for CRNAs The promise and peril of

Administered weekly, this medication showed users losing about 20.9% body weight in trials

The 59-year-old nurse began taking Zepbound in May 2025 after struggling with her health, low energy levels and stubborn weight gain

DejgaardTF,FrandsenCS,HansenTSetal.Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.Lancet Diabetes Endocrinol.2016;4(3):221 32

Hard-Boil Your Eggs Soft foods are often more appealing when nausea hits

Study limitations include the high heterogeneity of study characteristics which makes it difficult to reach any strong conclusions

The colour was scaled across samples for each gene